Access cutting-edge copd exacerbation treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Omaha location
Preparing your pre-screening questions…
Access copd exacerbation specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related copd exacerbation treatment provided free
Check if you qualify for this copd exacerbation clinical trial in Omaha, NE
No-Cost Study Care
Local to Omaha
Convenient for NE residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this observational study is to evaluate the safety and effectiveness of a home-monitoring device (RespirAI) in the early detection of COPD exacerbations in adults (age \>21) with physician-diagnosed COPD who are at high risk for exacerbations. The study will collect data from participants with COPD that will be analyzed using an AI-based algorithm to predict exacerbation events. The device's predictions will then be compared against clinically documented exacerbations to assess detection accuracy.
Sponsor: RespirAI US Inc
Yes, this clinical trial (NCT07554352) has an active research site in Omaha, NE that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for copd exacerbation treatment options in Omaha, NE, this clinical trial (NCT07554352) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd exacerbation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all copd exacerbation clinical trials near you to find additional studies recruiting in your area.
See all parkinsons disease clinical trials recruiting in Omaha — not just this study.
Browse Parkinsons Disease Trials in Omaha →